Tag: JAK3

Ritlecitinib also effective in patients with total hair loss

Presented By
Dr Melissa Piliang, Cleveland Clinic, USA
Trial
Phase 3, ALLEGRO
Conference
AAD 2024
Type
Peer-reviewed article

22 April 2024 14:57

Promising data for JAK inhibitors in Crohn’s disease from phase 2 trial

Presented By
Dr Séverine Vermeire, University Hospitals Leuven, Belgium
Trial
Phase 2, PIZZICATO
Conference
ECCO 2024
Type
Peer-reviewed article

18 April 2024 13:28

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By
Prof. Melissa Piliang, Cleveland Clinic, OH, USA
Trial
Phase 3, ALLEGRO
Conference
WCD 2023
Type
Peer-reviewed article

31 August 2023 15:18

Start low with brepocitinib and ritlecitinib in UC

Presented By
Dr Kenneth Hung, Pfizer, MA, USA
Trial
Phase 2, VIBRATO
Conference
UEGW 2022
Type
Peer-reviewed article

1 December 2022 21:34
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com